Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia

Clinica Chimica Acta

Volumn 260, Issue 1, 1997, Pages 49-64

  Gould, Barry J ^a   Davie, Sarah J ^a,c   Yudkin, John S ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c KINGSTON HOSPITAL   (United Kingdom)

Author keywords

2,3 Diphosphoglycerate; Fructosamine; Glucose permeability of erythrocytes; Glucose tolerance test; Glycated albumin; Glycated haemoglobin

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; AMINO ACID; FRUCTOSAMINE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLYCATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030899150     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06508-4     Document Type: Article

References (33)

1. Forrest RD, Jackson CA, Yudkin JS. Glucose intolerance and hypertension in North London. The Islington Diabetes Survey. Diabetic Med 1986;3:338-342.
2. Forrest RD, Jackson CA, Yudkin JS. The glycohaemoglobin assay as a screening test for diabetes mellitus. The Islington Diabetes Survey. Diabetic Med 1987;4:254-259.
3. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie SJ, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 1990;33:208-215.
4. 1, levels in normal glucose tolerance. Diabetes Care 1988;11:422-428.
5. 1c-distribution in a healthy population. Diabetologia 1989;32:864-869.
6. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-1321.
7. Monnier VM. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J Gerontol 1990;45:B105-111.
8. Higgins PJ, Garlick RL, Bunn HF. Glycosylated hemoglobin in human and animal red cells: role of glucose permeability. Diabetes 1982;31:743-748.
9. 1c formation. J Biol Chem 1985;260:11 611-11 618.
10. 1c formation in human erythrocytes in vitro. J Clin Invest 1982;69:1164-1168.
11. Watkins NG, Neglia-Fisher CI, Dyer DG, Thorpe SR, Baynes JW. Effect of phosphate on the kinetics and specificity of glycation of protein. J Biol Chem 1987;262:7207-7212.
12. Stolba P, Hátle K, Krnáková A, Streda M, Starka L. Effects of ascorbic acid on non-enzymatic glycation of serum proteins in vitro and in vivo. Diabetologia 1987;30:585 (abstract).
13. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes 1992;41:167-173.
14. Shepard DC, Hitz JB, Dain JA. Pyridoxal-5′-phosphate inhibits non-enzymatic glycosylation of proteins. Biochem Arch 1985;1:143-151.
15. Bridges K, Schmidt G, Jensen M, Cerami A, Bunn H. The acetylation of hemoglobin by aspirin: in vitro and in vivo. J Clin Invest 1975;56:201-207.
16. Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CH. Acetaldehyde adducts with hemoglobin. J Clin Invest 1981;67:361-369.
17. Flückiger R, Harman W, Meier W, Loo S, Gabbay KH. Hemoglobin carbamylation in uremia. N Engl J Med 1981;304:823-827.
18. Sensi M, Pricci F, De Rossi MG, Morano S, Di Mario U. D-Lysine effectively decreases the non-enzymic glycation of proteins in vitro. Clin Chem 1989;35:384-387.
19. 1c: slow glycosylation of haemoglobin in vivo. J Clin Invest 1976;57:1652-1659.
20. Gould BJ, Hall PM, Cook JGH. Measurement of glycosylated haemoglobins using an affinity chromatography method. Clin Chim Acta 1982;125:41-48.
21. 1c by thin-layer isoelectric focusing. J Chromatogr 1980;182:325-333.
22. Nathan DM, Dunn BS, Francis TB. Two commercial methods evaluated for eliminating the labile fraction from the assay for glycated hemoglobin (glycohemoglobin). Clin Chem 1984;30:109-110.
23. 1 by agar-gel electrophoresis. Clin Chem 1980;26:1598-1602.
24. John WG, Jones AE. Affinity chromatography: a precise method for glycosylated albumin estimation. Ann Clin Biochem 1985;22:79-83.
25. Warth J, Desforges JF. Intraerythrocyte pH and physiochemical homogeneity. Proc Soc Exp Biol Med 1978;159:136-138.
26. Brubacher G, Vuilleumer JP. Vitamin C. In: Curtius HC, Roth M, eds. Clinical biochemistry, Vol 2. Berlin: De Gruyter, 1974;989-997.
27. Peters T. Serum albumin. Adv Prot Chem 1985;37:161-245.
28. Olufemi S, Talwar D, Robb D. The relative extent of glycation of haemoglobin and albumin. Clin Chim Acta 1987;163:125-136.
29. Garlick RL, Mazer JS. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 1983;258:6142-6146.
30. Garlick RL, Mazer JS, Higgins PJ, Bunn HF. Characterization of glycosylated hemoglobins. J Clin Invest 1983;71:1062-1072.
31. 1c. FEBS Lett 1976;71:356-360.
32. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 1993;329:977-986.
33. Kilpatrick ES, Rumley AG, Dominiczak MH, Small M. Glycated haemoglobin values: problems in assessing blood glucose control in diabetes mellitus. Br Med J 1994;309:983-986.